Parvovirus B19 DNA detection by PCR Blood

Parvovirus B19 DNA Detection by PCR on blood is a molecular diagnostic test that identifies viral DNA from Parvovirus B19, enabling sensitive and specific detection of active infection. The assay can be performed qualitatively (presence/absence) or quantitatively (viral load in copies/mL) depending on clinical needs and is useful when serology is inconclusive or in early infection before antibody response develops.

This test is particularly important for pregnant women with suspected exposure (to assess fetal risk), patients with unexplained acute anemia or aplastic crises, and immunocompromised individuals with persistent fever or cytopenias. Touch Connect offers convenient at‑home venous blood collection across Dubai, UAE, with laboratory processing and timely reporting to support rapid clinical decision‑making by treating physicians.

• Parvovirus B19 DNA (Qualitative PCR)
• Parvovirus B19 DNA (Quantitative PCR — copies/mL)
• PCR Internal Control (sample/extraction integrity)

• Acute febrile illness with characteristic erythematous rash (fifth disease) or arthralgia
• Sudden or unexplained anemia, hemolytic crisis, or aplastic crisis
• Pregnant women with suspected exposure to Parvovirus B19
• Persistent anemia or fever in immunocompromised patients
• When serology (IgM/IgG) is inconclusive or early infection is suspected

• High sensitivity and specificity of PCR-based viral detection
• Quantitative viral load option for monitoring infection dynamics
• Convenient at‑home blood collection across Dubai, UAE
• Supports urgent clinical decisions in pregnancy and immunocompromised care
• Laboratory quality control with internal PCR controls for reliable reporting

• At‑home venous blood collection (EDTA tube) by a trained phlebotomist
• No fasting required prior to sample collection
• Inform the booking team if pregnant, recently transfused, or received IVIG
• Provide accurate symptom onset dates and referring clinician details for reporting